Abstract

A STUDY ON DETERMINATION OF COVID-19 SEVERITY IN DIABETIC AND NON DIABETIC PATIENT BASED ON CT SCORE AND ITS TREATMENT PATTERN: A RETROSPECTIVE COHORT STUDY

Abhijith Radhakrishnan, Adithya Prasad*, Allen Joseph, Dr. Akhila S. Arjun and Anitha Mary Mathews*

Abstract

Covid-19 infection became a global pandemic, first starting out of Wuhan, China spreading out to entire parts of the world, causing millions of deaths in its wake and is still an ongoing pandemic. The study on Diabetes and COVID-19 is important as management of covid-19 can only be done successfully once diabetes is brought under control. It was found that diabetes was associated with alterations in different parameters of COVID-19 severity indicating the need for more care in diabetic patients. The study deals to determine and categorize the severity of COVID-19 in diabetes and non diabetes patients. It was carried out among 160 COVID-19 patients out of which 74 were diabetic and 86 were non diabetic. Majority of patients were in age above 65 years. Out of 160 infected patients, 58.1% were male and 41.9% were female. Majority of the patients with diabetes mellitus belong to category B (39.2%) and category C (25.7%) whereas majority of non-diabetic patients belong to category A (48.8%). On analyzing treatment pattern, most of the patients received antibiotics, antivirals, anticoagulants and steroids. From this, anticoagulants and steroids were more prescribed in Diabetic COVID-19 patients. On interpreting mortality, 71.4% is diabetic death and 28.58% is non diabetic death. In this study we were able to demonstrate that diabetes is associated with increased risk of greater disease severity and poor short term outcome, which includes death. We concluded that management of diabetes is a must to lower complications associated with Covid-19.

Keywords: COVID - 19, Diabetes Mellitus, CT Score, FBS (Fasting Blood Sugar), Mortality.